Redmile Group, LLC Fate Therapeutics Inc Put Options Transaction History
Redmile Group, LLC
- $952 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FATE
# of Institutions
144Shares Held
96MCall Options Held
56.7KPut Options Held
5.4K-
Vanguard Group Inc Valley Forge, PA10.3MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$10.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.79MShares$7.87 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.29MShares$4.33 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.4MShares$3.43 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $98M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...